Roche Holding AG said on Wednesday the U.S. Food and Drug Administration (FDA) had approved its monoclonal antibody for treating COVID-19 in hospitalized adult patients.
A sign at a diagnostics site for Swiss pharmaceutical giant Roche is seen, in Burgess Hill, Britain, October 7, 2020. REUTERS/Peter Nichollssaid on Wednesday the U.S. Food and Drug Administration had approved its monoclonal antibody for treating COVID-19 in hospitalized adult patients.
The intravenous anti-inflammatory drug, Actemra, is a monoclonal antibody that reduces inflammation and was approved in 2010 to treat rheumatoid arthritis. It is the first FDA-approved monoclonal antibody to treat COVID-19, Roche said.In November, the regulator
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
COVID tally: COVID-19 hospitalizations are 11% higher than they were two weeks agoThere are about 40,000 COVID-19 hospitalizations in the U.S., a figure that is 11% higher than it was two weeks ago, according to the most recent update of a...
Lire la suite »
COVID Isolated People. Long COVID Makes It WorseThere's no question that COVID-19 cut people off from one another -- but for those who have long COVID, that disconnect has never really ended.
Lire la suite »
More than 60,000 LAUSD kids attend 2 optional days of school during winter break‘Acceleration days’ this week drew big response from 60,000 LAUSD students whose scores plummeted during COVID.
Lire la suite »
Undercounted Deaths Cloud China’s Zero-Covid ExitChina has reported just a handful of Covid-19 deaths as a wave of Omicron infections has swept the country, stoking suspicion that the government isn’t accurately accounting for the impact of the virus
Lire la suite »